Results

Total Results: 1,269 records

Showing results for "author year description".

121. Feeding and Nutrition Interventions in Cerebral Palsy | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/cerebral-palsy-feeding/research-protocol
     December 01, 2019 - Data suggest that during the first year of life, 57 percent of children with CP have sucking problems … evidence table may vary by KQ as appropriate, but the tables will contain some common elements, such as author … , year of publication, population and intervention descriptions, sample size, key outcomes, and study … Prevalence of cerebral palsy among ten-year-old children in metropolitan Atlanta, 1985 through 1987. … A priori' methods of assessment should be provided (e.g., for effectiveness studies if the author(s)

122. Mindfulness-Based Interventions for Wellbeing and Mental Health in Children and Adolescents: A Systematic Review (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ped-mindfulness-protocol-amendment.pdf
     February 05, 2025 - Contacting Author. … in the included studies, we will consider using a framework such as the Template for Intervention Description … Better reporting of interventions: template for intervention description and replication (TIDieR) checklist … = Satisfaction with Life Scale; TCA = tricyclic antidepressant; TIDieR = Template for Intervention Description … The revised protocol adjusted the starting date of the search to the year 2009.

123. Disposition of Comments Report for Biologic and Nonbiologic Systemic Agents and Phottherapy for Treatment of Chronic Plaque Psoriasis (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/psoriasis-chronic_disposition-comments.pdf
     November 27, 2012 - Etanercept is 64 shots in the 1st year, adalimumab is 28 shots in the 1st year, and ustekinumab is 5 … shots in the 1st year of therapy. … For example a brief description of each scale chosen, and some reasoning why these scales were chosen … The description of comparisons is provided in the text above the table. 8. … Please include a description of the methodology for the CHAMPION trial Thank you for this comment.

124. Disposition of Comments for CER 157 Appendicitis (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/appendicitis_disposition-comments.pdf
     December 14, 2015 - Peer Reviewer #5 Introduction In your description of the clinical symptoms and signs suggestive … We think that year of publication cut-offs are not appropriate because technology diffusion happens … Did you notice any differences based on publication year? … Please note that 1956 was not a cut-off year chosen by us, it is simply a reflection of the indexing … We have attempted to capture the evolution of the technology by examining subgroups by year of study

125. Disposition of Comments Report for The Clinical Utility of Fractional Exhaled Nitric Oxide (FeNO) in Asthma Management (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-197-fractional-exhaled-nitric-oxide-disposition-comments.pdf
     December 20, 2017 - The first is a paper that was presented in Germany the same day as ref 6, but published the next year … with the diagnostic meta- analysis estimates for sensitivity, specificity, likelihood ratios and a description … The tables in the appendix follow a standard EPC format (search strategy, excluded studies, description … I did not find the an explicit description of the intended audience No other concerns.

126. Disposition of Comments_Comparative Effectiveness Review No. 253: Maternal and Child Outcomes Associated With the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/maternal-child-outcomes-wic-disposition-comments.pdf
     April 19, 2022 - outcomes-nutrition/research Published Online: April 19, 2022 2 Summary of Peer Reviewer Comments and Author … products/outcomes-nutrition/research Published Online: April 19, 2022 3 Public Comments and Author … Association (NWA) Introduction The introduction section similarly is accurate and detailed in its description … Thank you National WIC Association (NWA) Methods Include a brief description on the funding sources … We have edited as suggested National WIC Association (NWA) Discussion WIC’s funding description

127. Disposition of Comments_Comparative Effectiveness Review No. 267: ADHD Diagnosis and Treatment in Children and Adolescents (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-267-adhd-disposition-comments.pdf
     March 25, 2024 - Summary of Peer Reviewer Comments and Author … Public Comments and Author Response Commentator & Affiliation Section Comment Response Meena … youth younger than 7, but that also may be the case for adolescents, as most studies focus on 6-11 year … , year). … Response Public Comments and Author Response

128. Disposition of Comments for Evidence Report 220 Health Information Exchange (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/health-information-exchange-disposition-160504.pdf
     December 15, 2015 - TEP Reviewer #5 Introduction A very clear description of the current state of the literature and its … Peer Reviewer #8 Results Page 29 line 12: out in the year as this will not stad the "test of time" … However the description of push system was not clear to me. c. … For example, a dump of all filled prescriptions organized by dispensing data for the last year will … The 5-year survival of all start-up businesses is about 10%.

129. Disposition of Comments for Technical Brief 18 Public Reporting of Cost Measures in Health (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/public-reporting-cost-measures_disposition-comments.pdf
     March 05, 2015 - The guiding questions cover the following: a description of the measures of cost that have been publicly … Based on that description, the Maine website also sounded to me like the website was giving data on … Recommend more nuanced description of next steps needed to further validate, rather than only how the … I did not see any description of other grading systems? … Reviewer#4 General Comments This is a very nicely executed scan and description of public reporting

130. Disposition of Comments Report for Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Tests for Evaluating Musculoskeletal Complaints in Children (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/musculoskeletal-complaints-tests-children_disposition-comments.pdf
     March 07, 2012 - Clearly newborns barely make immunoglobulin whereas 18 year olds have adult levels. … None of the studies looked specifically at children with joint swelling; we added this to the description … We have reworded the outcome description for KQ5. … Outcome of high titer ANA positivity in individuals w/o connective tissue disease: 10 year followup … Outcome of high titer ANA positivity in individuals w/o connective tissue disease: 10 year followup

131. Finding Grey Literature Evidence and Assessing for Outcome and Analysis Reporting Biases When Comparing Medical Interventions: AHRQ and the Effective Health Care Program | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/methods-guidance-reporting-bias/methods
     December 01, 2019 - of the project or fiscal year of funding. … When trying to contact a study author, there is little guidance as to how many times this should be attempted … reviewers conducted by Mullan, et al. 84 reported that most respondents contacted at least one study author … Trying to contact one study author three times and other study authors once is systematically different … FDA Web Site – Drugs@FDA Agency URL Description Abbreviations: FDA = U.S.

132. Disposition of Comments for Technical Brief 31 Mobile Applications for Self-Management of Diabetes (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/tech-brief-31-mobile-applications-self-mgmt-disposition-comments.pdf
     May 08, 2018 - I think the key concept for all reviews is transparency and realistic description of the results as … Key Informant #4 General Page 10, description of mHealth evaluation, this section is much too brief … Peer Reviewer #1 Findings The Description of Apps section is useful. … Unfortunately, the app names did not fit into this graph, but we put the citation by each (Author, … Year) so readers could trace the citation across different sections of the report.

133. Disposition of Comments for Treatment of Glaucoma: Comparative Effectiveness (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/glaucoma-treatment_disposition-comments.pdf
     April 01, 2012 - This should be done using Corporate Author and keyword searches. … The Corporate Author search alone is not reliable. … Three-year follow-up of the tube versus trabeculectomy study. … Also, as the author points out, there is no formal economic analysis comparing trabeculectomy, laser … A description of the studies included precedes this paragraph, but there is no description or metaanalysis

134. Observed Association Between Antidepressant Use and Pneumonia Risk Was Confounded by Comorbidity Measures (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/antidepressants-seniors-pneumonia_research.pdf
     May 01, 2008 - ..................................................................................... 13 Author … The odds ratio (OR) for any antidepressant use, adjusting for age, sex, and calendar year was 1.61 ( … The OR for any antidepressant use, adjusted for age, sex, and calendar year was 1.45 (0.65 to 3.24). … Code Description AyuKA00 KLEBSIELLA PNEUMONIAE/CAUSE/DISEASE CLASSIFD/OTH CHAPTERS AyuK900 MYCOPLASMA … Code Description Hyu4700 [X]PNEUMONITIS DUE TO INHALATION OF OTHER SOLIDS AND LIQUIDS H470312 ASPIRATION

135. Registry of Patient Registries (RoPR): Project Overview (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/registry-of-patient-registries_research-2012-3_0.pdf
     January 01, 2012 - ...........................4 Effective Health Care Program Research Report Number 40 v Author … Registry Description—identification and description information. 2.

136. PHS 398 (Rev. 9/04), Continuation Page (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/upenn-final-report-2005-certs-ce-supplement.pdf
     January 01, 2005 - Only about 5% of SCD cases survive.4 SCD results in 300,000-456,000 deaths per year, or about 12-19% … SCD is 1.8 per 1000 in the general US population,9 which mirrors the rate of about 2 per 1000 per year … SCD/VA ICD-9 diagnosis codes ICD-9 Code Description 427.1 Paroxysmal Ventricular Tachycardia; Ventricular

137. PHS 398 (Rev. 9/04), Continuation Page (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/administrative-data-validity_research.pdf
     January 01, 2007 - Only about 5% of SCD cases survive.4 SCD results in 300,000-456,000 deaths per year, or about 12-19% … SCD is 1.8 per 1000 in the general US population,9 which mirrors the rate of about 2 per 1000 per year … SCD/VA ICD-9 diagnosis codes ICD-9 Code Description 427.1 Paroxysmal Ventricular Tachycardia; Ventricular

138. Disposition of Comments Report for Vitamin D and Calcium: A Systematic Review of Health Outcomes (Update) (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/vitamin-d-calcium_disposition-comments.pdf
     September 15, 2014 - However we have now clarified the description and moved it so that it appears after the description … standard” and added more detail about the use of NIST and DEQAS standards as well as reporting the year … breast and colorectal cancer and for hip fracture conducted by Prentice and colleagues of the 7- year … Description of results in Table 33B report the increased risk at higher 25OHD levels. … MS, irrespective of year, country etc.

139. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_disposition-comments.pdf
     March 10, 2010 - Methods We find it unfortunate that the literature searches ended over a year ago. … Considerable literature has been published in the past year that is directly relevant to the subject … A systematic review that fails to include information that is as much as a year old is not a useful … Timelines: Letters from Chalmers to lead authors: April 16 to May 2, 2008 Forwarded to Merck by lead author … in the population description with ?muscle-related side effects.?

140. Disposition of Comments Report for Local Hepatic Therapies for Metastases to the Liver From Unresectable Colorectal Cancer (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/colorectal-cancer-liver-metastases-therapies_disposition-comments.pdf
     December 11, 2012 - The 5-year survival rate estimated by the National Cancer Institute Surveillance Epidemiology and End … The description of the review and the summary provided clearly shows that all relevant studies have … This study was excluded since it was thought that studies with treatment interventions prior to year … Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation … The article by Solibati et al was excluded due to a treatment period before year 2000.